Roche
ROG.SW
$241.68
Share price
1.01%
Change (1 day)
-23.95%
Change (1 year)
Categories
EPS for Roche (ROG.SW)
EPS in 2022: $16.80
According to Roche's latest financial reports the company's current EPS (TTM) is $16.80. In 2022 the company made an earnings per share (EPS) of $16.80 a decrease over its 2021 EPS that were of $17.93.
EPS history for Roche from 2001 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 | $16.80 | -6.29% |
| 2021 | $17.93 | -5.53% |
| 2020 | $18.98 | 16.56% |
| 2019 | $16.28 | 30.3% |
| 2018 | $12.49 | 20.22% |
| 2017 | $10.39 | -5.81% |
| 2016 | $11.03 | 4.62% |
| 2015 | $10.55 | -5.13% |
| 2014 | $11.12 | -25.05% |
| 2013 | $14.83 | 21.73% |
| 2012 | $12.18 | 3.82% |
| 2011 | $11.74 | 8.16% |
| 2010 | $10.85 | 23.72% |
| 2009 | $8.77 | -12.31% |
| 2008 | $10.00 | -0.34% |
| 2007 | $10.04 | 32.13% |
| 2006 | $7.59 | 42.56% |
| 2005 | $5.33 | -22.7% |
| 2004 | $6.89 | 132.85% |
| 2003 | $2.96 | -154.73% |
| 2002 | -$5.41 | -209.09% |
| 2001 | $4.96 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -16.16% | 🇺🇸 USA |
 Novartis NVS | $3.74 | -77.74% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | -88.93% | 🇺🇸 USA |
 Abbott Laboratories ABT | $2.97 | -82.31% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | -15.77% | 🇺🇸 USA |
 Sanofi SNY | $3.18 | -81.07% | 🇫🇷 France |
 Becton Dickinson BDX | $5.55 | -66.96% | 🇺🇸 USA |
 Merck MRK | $1.82 | -89.16% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -79.16% | 🇬🇧 UK |